TENX logo

Tenax Therapeutics (TENX) Cash From Financing

Annual CFF

$13.57 M
+$5.64 M+71.10%

December 31, 2023

Summary

Performance

1-Year Change

+71.1%

3-Year Change

+28.05%

5-Year Change

+52.34%

15-Year Change

+100%

TENX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

61.51%
TENX annual cash flow from financing activities is higher than 61.51% of companies in Healthcare sector

High & Low

All-time High

$66.95 M
TENX annual cash flow from financing activities is currently -79.73% below its historical high of $66.95 million

3-Year Low

$7.93 M
TENX annual cash flow from financing activities is currently +71.10% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
TENX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 14, 2025
TENX next annual earnings announcement is scheduled for May 14, 2025

OtherTENXcash flowmetrics:

Annual CFI

$2800.00
TENX annual cash flow from investing activities is $2800.00

Annual CFO

-$5.90 M
TENX annual cash flow from operations is -$5.90 million

Annual FCF

-$5.90 M
TENX annual free cash flow is -$5.90 million

Annual CAPEX

-
TENX annual capital expenditures value is unknown

Quarterly CFF

$92.01 M
+$92.15 M+68562.95%

September 30, 2024

Summary

Performance

3-Month Change

+68562.95%

1-Year Change

+1061.37%

3-Year Change

+92206.31%

5-Year Change

+92206.31%

TENX Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

95.13%
TENX quarterly cash flow from financing activities is higher than 95.13% of companies in Healthcare sector

High & Low

All-time High

$92.01 M
TENX quarterly cash flow from financing activities is currently at an all-time high

3-Year Low

-$174.50 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
TENX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 14, 2025
TENX next earnings announcement is scheduled for May 14, 2025

OtherTENXcash flowmetrics:

Quarterly CFI

$0.00
TENX quarterly cash flow from investing activities is $0.00

Quarterly CFO

-$3.09 M
TENX quarterly cash flow from operations is -$3.09 million

Quarterly FCF

-$3.09 M
TENX quarterly free cash flow is -$3.09 million

Quarterly CAPEX

-
TENX quarterly capital expenditures value is unknown

TTM CFF

$99.63 M
+$92.19 M+1238.60%

September 30, 2024

Summary

Performance

3-Month Change

+1238.6%

1-Year Change

+1232.43%

3-Year Change

+620.63%

5-Year Change

+620.63%

TENX TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

82.07%
TENX TTM cash flow from financing activities is higher than 82.07% of companies in Healthcare sector

High & Low

All-time High

$99.63 M
TENX TTM cash flow from financing activities is currently at an all-time high

3-Year Low

$7.44 M
TENX TTM cash flow from financing activities is currently +1238.60% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
TENX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 14, 2025
TENX next earnings announcement is scheduled for May 14, 2025

OtherTENXcash flowmetrics:

TTM CFI

$0.00
TENX TTM cash flow from investing activities is $0.00

TTM CFO

-$12.46 M
TENX TTM cash flow from operations is -$12.46 million

TTM FCF

-$12.46 M
TENX TTM free cash flow is -$12.46 million

TTM CAPEX

-
TENX TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

TENX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+71.1%+1061.4%+1232.4%
3 y3 years+28.1%+10000.0%+620.6%
5 y5 years+52.3%+10000.0%+620.6%

TENX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+71.1%at high>+9999.0%at high+1238.6%
5 y5-yearat high>+9999.0%at high>+9999.0%at high>+9999.0%
alltimeall time-79.7%>+9999.0%at high+716.9%at high+763.3%

Tenax Therapeutics Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$92.01 M(<-9900.0%)
$99.63 M(+1238.6%)
Jun 2024
-
-$134.40 K(-101.7%)
$7.44 M(-0.5%)
Mar 2024
-
$7.92 M(-4640.3%)
$7.48 M(-44.9%)
Dec 2023
$13.57 M(+71.1%)
-$174.50 K(+1.9%)
$13.57 M(-1.3%)
Sep 2023
-
-$171.30 K(+71.5%)
$13.75 M(-0.6%)
Jun 2023
-
-$99.90 K(-100.7%)
$13.83 M(-36.3%)
Mar 2023
-
$14.01 M(>+9900.0%)
$21.72 M(+173.8%)
Dec 2022
$7.93 M(-18.6%)
$2100.00(-102.3%)
$7.93 M(+0.0%)
Sep 2022
-
-$91.90 K(-101.2%)
$7.93 M(-53.9%)
Jun 2022
-
$7.79 M(+3305.5%)
$17.21 M(+82.7%)
Mar 2022
-
$228.80 K(>+9900.0%)
$9.42 M(-3.2%)
Dec 2021
$9.74 M(-8.1%)
$0.00(-100.0%)
$9.74 M(+0.0%)
Sep 2021
-
$9.19 M(>+9900.0%)
$9.74 M(+37.6%)
Jun 2021
-
$0.00(-100.0%)
$7.08 M(-21.5%)
Mar 2021
-
$544.70 K(<-9900.0%)
$9.01 M(-15.0%)
Dec 2020
$10.60 M(>+9900.0%)
-$1400.00(-100.0%)
$10.60 M(-0.0%)
Sep 2020
-
$6.53 M(+237.6%)
$10.60 M(+160.7%)
Jun 2020
-
$1.94 M(-9.1%)
$4.07 M(+90.9%)
Mar 2020
-
$2.13 M(>+9900.0%)
$2.13 M(+2107.3%)
Dec 2019
$96.50 K(-98.9%)
$0.00(0.0%)
$96.50 K(-98.9%)
Sep 2019
-
$0.00(0.0%)
$9.00 M(0.0%)
Jun 2019
-
$0.00(-100.0%)
$9.00 M(0.0%)
Mar 2019
-
$96.50 K(-98.9%)
$9.00 M(+1.1%)
Dec 2018
$8.91 M(>+9900.0%)
$8.91 M(>+9900.0%)
$8.91 M(>+9900.0%)
Sep 2018
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2018
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2018
-
$0.00(-100.0%)
$0.00(-100.0%)
Dec 2017
$0.00(-100.0%)
-
-
Dec 2015
-$100.20 K(-135.7%)
-
-
Oct 2015
-
-$48.40 K(-6.6%)
-$47.00 K(+221.9%)
Jul 2015
-
-$51.80 K(+1.4%)
-$14.60 K(-106.3%)
Apr 2015
$280.60 K(-99.6%)
-$51.10 K(+8.7%)
$233.60 K(-17.9%)
Mar 2015
-
-$47.00 K(-131.1%)
$284.70 K(-99.5%)
Jan 2015
-
$151.30 K(-1045.6%)
$55.33 M(-10.4%)
Oct 2014
-
-$16.00 K(-108.1%)
$61.72 M(-0.9%)
Jul 2014
-
$196.40 K(-99.6%)
$62.26 M(-7.0%)
Apr 2014
$66.95 M(+1585.1%)
$54.99 M(+740.1%)
$66.95 M(+400.0%)
Jan 2014
-
$6.55 M(+1161.8%)
$13.39 M(+93.1%)
Oct 2013
-
$518.80 K(-89.4%)
$6.93 M(+8.3%)
Jul 2013
-
$4.89 M(+240.0%)
$6.40 M(+61.1%)
Apr 2013
$3.97 M(-58.0%)
$1.44 M(+1470.7%)
$3.97 M(+52.3%)
Jan 2013
-
$91.50 K(-753.6%)
$2.61 M(-57.3%)
Oct 2012
-
-$14.00 K(-100.6%)
$6.11 M(-9.3%)
Jul 2012
-
$2.46 M(+3258.3%)
$6.74 M(-28.8%)
Apr 2012
$9.47 M(+3.1%)
$73.20 K(-98.0%)
$9.47 M(-18.9%)
Jan 2012
-
$3.60 M(+489.1%)
$11.67 M(+15.2%)
Oct 2011
-
$610.60 K(-88.2%)
$10.13 M(+6.6%)
Jul 2011
-
$5.19 M(+128.1%)
$9.50 M(+3.4%)
Apr 2011
$9.19 M
$2.27 M(+10.3%)
$9.19 M(+29.0%)
Jan 2011
-
$2.06 M(<-9900.0%)
$7.12 M(-32.6%)
DateAnnualQuarterlyTTM
Oct 2010
-
-$19.90 K(-100.4%)
$10.57 M(+0.5%)
Jul 2010
-
$4.87 M(+2235.3%)
$10.52 M(+45.9%)
Apr 2010
$7.21 M(+243.1%)
$208.60 K(-96.2%)
$7.21 M(+5.2%)
Jan 2010
-
$5.51 M(-7729.4%)
$6.85 M(+387.0%)
Oct 2009
-
-$72.20 K(-104.6%)
$1.41 M(-9.0%)
Jul 2009
-
$1.56 M(-1173.7%)
$1.55 M(-26.4%)
Apr 2009
$2.10 M(-71.0%)
-$145.40 K(-328.6%)
$2.10 M(-69.7%)
Jan 2009
-
$63.60 K(-4.9%)
$6.93 M(-22.7%)
Oct 2008
-
$66.90 K(-96.8%)
$8.97 M(-2.5%)
Jul 2008
-
$2.12 M(-54.9%)
$9.19 M(+26.9%)
Apr 2008
$7.24 M(+517.6%)
$4.69 M(+123.3%)
$7.24 M(+166.7%)
Jan 2008
-
$2.10 M(+616.4%)
$2.72 M(+162.9%)
Oct 2007
-
$293.00 K(+78.1%)
$1.03 M(-5.2%)
Jul 2007
-
$164.50 K(+3.3%)
$1.09 M(-7.1%)
Apr 2007
$1.17 M(-27.4%)
$159.30 K(-61.7%)
$1.17 M(-0.4%)
Jan 2007
-
$416.30 K(+19.2%)
$1.18 M(+54.7%)
Oct 2006
-
$349.10 K(+40.7%)
$761.20 K(+84.7%)
Jul 2006
-
$248.10 K(+51.5%)
$412.10 K(-74.5%)
Apr 2006
$1.62 M(-32.2%)
$163.80 K(>+9900.0%)
$1.62 M(+1.4%)
Jan 2006
-
$200.00(>+9900.0%)
$1.59 M(-50.6%)
Oct 2005
-
$0.00(-100.0%)
$3.23 M(0.0%)
Jul 2005
-
$1.45 M(+931.4%)
$3.23 M(+35.2%)
Apr 2005
$2.39 M(+19.1%)
$140.80 K(-91.4%)
$2.39 M(+1.7%)
Jan 2005
-
$1.63 M(>+9900.0%)
$2.34 M(+57.6%)
Oct 2004
-
$0.00(-100.0%)
$1.49 M(-6.8%)
Jul 2004
-
$612.00 K(+512.0%)
$1.60 M(-20.3%)
Apr 2004
$2.00 M(-2003.2%)
$100.00 K(-87.1%)
$2.00 M(+5.3%)
Jan 2004
-
$776.00 K(+617.9%)
$1.90 M(+71.9%)
Oct 2003
-
$108.10 K(-89.4%)
$1.11 M(+14.3%)
Jul 2003
-
$1.02 M(>+9900.0%)
$968.00 K(-1020.2%)
Apr 2003
-$105.20 K(-122.6%)
$0.00(-100.0%)
-$105.20 K(-99.3%)
Jan 2003
-
-$19.80 K(-34.7%)
-$15.02 M(<-9900.0%)
Oct 2002
-
-$30.30 K(-45.0%)
$21.80 K(-54.6%)
Jul 2002
-
-$55.10 K(-99.6%)
$48.00 K(-89.7%)
Apr 2002
$465.50 K(-27.2%)
-$14.91 M(-199.3%)
$465.60 K(-97.0%)
Jan 2002
-
$15.02 M(<-9900.0%)
$15.48 M(+2522.3%)
Oct 2001
-
-$4100.00(-101.1%)
$590.50 K(+3.2%)
Jul 2001
-
$362.50 K(+246.9%)
$572.00 K(-10.6%)
Apr 2001
$639.60 K(-89.7%)
$104.50 K(-18.1%)
$639.60 K(-89.8%)
Jan 2001
-
$127.60 K(-664.6%)
$6.27 M(-1.1%)
Oct 2000
-
-$22.60 K(-105.3%)
$6.35 M(-3.4%)
Jul 2000
-
$430.10 K(-92.5%)
$6.57 M(+5.3%)
Apr 2000
$6.24 M(+1459.7%)
$5.74 M(+2769.3%)
$6.24 M(+1147.7%)
Jan 2000
-
$200.00 K(0.0%)
$500.00 K(+66.7%)
Oct 1999
-
$200.00 K(+100.0%)
$300.00 K(+200.0%)
Jul 1999
-
$100.00 K
$100.00 K
Apr 1999
$400.00 K(-69.5%)
-
-
Apr 1998
$1.31 M(+47.2%)
-
-
Apr 1997
$891.80 K(-0.1%)
-
-
Apr 1996
$892.80 K
-
-

FAQ

  • What is Tenax Therapeutics annual cash flow from financing activities?
  • What is the all time high annual CFF for Tenax Therapeutics?
  • What is Tenax Therapeutics annual CFF year-on-year change?
  • What is Tenax Therapeutics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Tenax Therapeutics?
  • What is Tenax Therapeutics quarterly CFF year-on-year change?
  • What is Tenax Therapeutics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Tenax Therapeutics?
  • What is Tenax Therapeutics TTM CFF year-on-year change?

What is Tenax Therapeutics annual cash flow from financing activities?

The current annual CFF of TENX is $13.57 M

What is the all time high annual CFF for Tenax Therapeutics?

Tenax Therapeutics all-time high annual cash flow from financing activities is $66.95 M

What is Tenax Therapeutics annual CFF year-on-year change?

Over the past year, TENX annual cash flow from financing activities has changed by +$5.64 M (+71.10%)

What is Tenax Therapeutics quarterly cash flow from financing activities?

The current quarterly CFF of TENX is $92.01 M

What is the all time high quarterly CFF for Tenax Therapeutics?

Tenax Therapeutics all-time high quarterly cash flow from financing activities is $92.01 M

What is Tenax Therapeutics quarterly CFF year-on-year change?

Over the past year, TENX quarterly cash flow from financing activities has changed by +$84.09 M (+1061.37%)

What is Tenax Therapeutics TTM cash flow from financing activities?

The current TTM CFF of TENX is $99.63 M

What is the all time high TTM CFF for Tenax Therapeutics?

Tenax Therapeutics all-time high TTM cash flow from financing activities is $99.63 M

What is Tenax Therapeutics TTM CFF year-on-year change?

Over the past year, TENX TTM cash flow from financing activities has changed by +$92.15 M (+1232.43%)